Review ArticleCytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts
Section snippets
Endothelial Dysfunction and Atherosclerosis
The vascular endothelium is an anatomical barrier that protects the vessel from the potentially harmful consequences of toxic substances, helps to maintain vascular homeostasis and tone, regulates local cellular activity, and modulates hemostatic, inflammatory, and reparative responses to injurious agents. It is also an active interface between the circulating blood and the vessel wall. Heightened inflammation through elevated oxidative stress and endothelial dysfunction is thought to promote
Role of Adipose Tissue in Cardiometabolic Health
Obesity and the metabolic syndrome have greatly impacted the incidence and severity of cardiovascular complications. Central obesity, one of the components of metabolic syndrome, is a cardiometabolic risk factor associated with a state of chronic inflammation and coagulation. Dysregulation of pro- and antiinflammatory adipocytokine function and production is associated with visceral fat obesity and the metabolic syndrome, suggesting that inflammation may contribute to the development of the
Inflammatory Markers in the Metabolic Syndrome: Nontraditional Risk Factors
Inflammation is regarded as a contributor to morbidity in the closely related conditions of CVD, obesity, the metabolic syndrome, and type 2 diabetes and has been the focus of extensive research recently.18., 28. Inflammatory markers CRP, fibrinogen, the ILs, TNF-α, PAI-1, and serum amyloid A (SAA) have been included in the ever-expanding list of emerging or nontraditional risk factors for the atherosclerotic process29 (Table 2). They mirror oxidative stress and generation of free radicals that
To Screen or Not to Screen?
Although the field of emerging risk factors has seen rapid advances, the issue of using them for disease screening is controversial.41., 42. Because CVD and the metabolic syndrome are closely linked, any discussion of cardiac risk factors must necessarily overlap with the criteria designated for the metabolic syndrome. The traditional risk factors for CVD – positive family history, hypertension, diabetes, dyslipidemia, and smoking – explain a preponderant amount of morbidity and mortality,
C-Reactive Protein: Marker or Mediator?
CRP is a member of the pentraxin family, which consists of 5 noncovalently associated peptides surrounding a central core. It is an acute-phase reactant that is synthesized in the liver and activates the classical pathway of complement through the immune system. It is the best-known marker of inflammation and has been touted as an independent risk factor for CVD on the basis of recent studies. Various proinflammatory cytokines, such as TNF and IL-1 derived from vascular endothelium and adipose
Adiponectin
Adiponectin is produced by adipocytes and has remarkable properties that inhibit inflammation and enhance insulin sensitivity, glucose transport, and fatty acid oxidation. Low levels of adiponectin are found in subjects with diabetes and obesity, and correlate with insulin resistance and the future development of glucose intolerance and the metabolic syndrome. It has been shown to suppress endothelial dysfunction, lipid accumulation, smooth muscle proliferation and to inhibit atherosclerotic
Relationship Between CRP and the Adipocytokines
CRP is strongly associated with adipose-derived cytokines, including IL-6 and TNF-α.74., 75. These are likely to be elevated in obese insulin-resistant subjects, especially in those with upper-body fat deposition, but not generally in obese subjects who are insulin sensitive.55 In addition, several other markers of inflammation correlate with both insulin resistance and hyperinsulinemia. Because they are also elevated in obesity and in the presence of cardiovascular risk factors,50 they provide
Interleukin-6
IL-6 is a cytokine that is produced largely in omental fat. It seems to exert its metabolic actions through its actions both in the central nervous system (CNS) and on peripheral organs. It is released in response to stress and stimulation of the sympathetic nervous system. Several studies point to it being a central mediator of the inflammatory response, and it tends to correlate closely with CRP76., 77. and the presence of multiple features of the metabolic syndrome.78 It increases hepatic
Tumor Necrosis Factor-α
TNF-α is produced largely by adipose tissue and also by macrophages and endothelial cells. Its levels correlate with the amount of adipose tissue, and it has a role in modulating insulin sensitivity.80 It has been linked to the increase in insulin resistance seen with obesity,81 although a consistent correlation of TNF-α with BMI has not been conclusively demonstrated. Although it has been implicated in states of increased insulin resistance, passive immunization with antibodies to TNF-α does
Leptin
An important adipocytokine that acts directly on the hypothalamus, and it regulates food intake and energy expenditure. Hypoleptinemia has been linked to weight gain, fat deposition in organs, such as the liver, muscle, and pancreatic islets, clinical features of the metabolic syndrome, and a general proinflammatory state.82 Leptin is secreted by adipocytes and binds to receptors in the CNS, where it suppresses appetite and decreases food intake. In the peripheral tissues, it enhances insulin
Resistin
Additional research has unveiled another adipocyte-derived cytokine, resistin, that is elevated in obesity and impaired glucose tolerance. It seems to be correlated with markers of inflammation and to be predictive of coronary atherosclerosis and type 2 diabetes in humans. However, its role in the genesis and pathophysiology of the metabolic syndrome remains to be fully elucidated. Plasma resistin levels are highly positively correlated with triglycerides, waist circumference, waist/hip ratio,
A Unifying Hypothesis
A mechanistic pathway linking the conventional and nontraditional risk factors in the pathophysiology of the metabolic syndrome is illustrated in Figure 2. On the basis of research done thus far, the inflammatory cytokines are critical in affecting the balance of endothelial health: obesity, insulin resistance, stress, presence of the metabolic syndrome components, and other acute or chronic insults tend to tilt the balance toward a more proinflammatory picture and lead to an environment
Should the Inflammatory Markers Be Used in Screening for Health Risk and as Therapeutic Targets?
There is currently no consensus in using the markers of inflammation as screening tools or as risk factors to be targeted. This area seems to be embroiled in controversy and confusion,41 although some recommendations have been put forth.31 The argument for testing of individuals at moderate risk for CVD is based on further stratifying their risk status and assisting in clinical management. On the other hand, some contend that the role of these acute-phase reactants in disease causation is not
CONCLUSION
The phenomenal increase in the prevalence of obesity and the metabolic syndrome has accentuated the various clinical manifestations and pathopysiologic underpinnings of this epidemic. Although the major pathophysiologic mechanisms are still in the process of being elucidated, the possible role of inflammation, cytokines, and atherogenic markers in the metabolic syndrome has received attention lately. Taken together, these abnormalities shift the balance of endothelial function toward an
REFERENCES (92)
- et al.
The metabolic syndrome: prevalence in worldwide populations
Endocrinol Metab Clin North Am
(2004) - et al.
Endothelial inflammation in insulin resistance
Lancet
(2005) The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X
Brain Behav Immun
(2003)- et al.
Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis
Clin Chim Acta
(2007) - et al.
Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links
Eur Urol
(2007) - et al.
Prevalence of non-traditional cardiovascular risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III)
Ann Epidemiol
(2004) Diabetes mellitus: a hypercoagulable state
J Diabetes Complications
(2001)- et al.
Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes patients with retinopathy and nephropathy
J Diabetes Complications
(2000) - et al.
Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus
J Diabetes Complications
(2003) Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol, and pentoxifylline
Med Hypotheses
(1999)
Leptin, from fat to inflammation: old questions and new insights
FEBS Lett
Longevity, lipotoxicity, and leptin: the adipocyte defense against feasting and famine
Biochimie
The emerging role of adipokines as mediators of inflammation and immune responses
Cytokine Growth Factor Rev
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults
Metabolism
Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor’s clothes fit?
Diabetes Care
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease
Diabetologia
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
Arterioscler Thromb Vasc Biol
Inflammation, atherosclerosis, and coronary artery disease
N Engl J Med
Molecular mechanisms of impaired endothelial function associated with insulin resistance
Curr Drug Targets Cardiovasc Haematol Disord
Metabolic syndrome and type 2 diabetes: lipid and physiological consequences
Diab Vasc Dis Res
Insulin resistance and chronic cardiovascular inflammatory syndrome
Endocr Rev
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease
Diabetologia
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
JAMA
American College of Endocrinology position statement on the insulin resistance syndrome
Endocr Pract
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report, National Institutes of Health
Obes Res
High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9–12 years
Diabetes Care
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome—an analysis by structural equation modeling
Int J Obes Relat Metab Disord
Inflammation, the metabolic syndrome and cardiovascular risk
Int J Clin Pract Suppl
Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective
Angiology
Albuminuria and chronic kidney disease in association with the metabolic syndrome
J Cardiometab Syndr
The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events
J Clin Endocrinol Metab
Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis
J Rheumatol
Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic liver disease
Curr Opin Clin Nutr Metab Care
A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α
Arterioscler Thromb Vasc Biol
Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis
Arterioscler Thromb Vasc Biol
C-reactive protein and other markers of inflammation in the prediction of coronary heart disease
N Engl J Med
Role of endothelial dysfunction in insulin resistance
Am J Cardiol
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
Circulation
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
N Engl J Med
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
N Engl J Med
Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study
Diabetes Metab Res Rev
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death
Diabetes
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study
Diabetes
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
Diabetes
Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients
Diabetalogia
Cited by (89)
Development of lady beetle attractants from floral volatiles and other semiochemicals for the biological control of aphids
2020, Journal of Asia-Pacific EntomologyMulti-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)
2019, Life SciencesCitation Excerpt :On the other side, the increase of TNF-α could promote the phosphorylation of PIMT at an ERK2 target site to inhibit the expression of GLUT4, MEF2A and HDAC5, which could downregulate glucose uptake to induce IR [67]. Furthermore, accumulating IL-6 and TNF-α can induce endothelial dysfunction via reduced vasodilation and decreased nitric oxide (NO) synthesis [68]. NO-mediated signaling attenuation in blood vessels and platelets has been demonstrated in PCOS women, which may lead to a common complication that premature atherogenesis [69].
Implications and Future Perspectives of AGEs in PCOS Pathophysiology
2019, Trends in Endocrinology and MetabolismAdvanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?
2015, Metabolism: Clinical and ExperimentalEffects of a dietary strawberry powder on parameters of vascular health in adolescent males
2016, British Journal of NutritionCancer cachexia: biomarkers and the influence of age
2024, Molecular Oncology